Inventor · disambiguated record
Calvin W. Yee
Also filed as: YEE CALVIN · YEE CALVIN W · YEE CALVIN WESLEY
16 granted patents·9 pending applications·176 citations·filing 2009–2024
91Inventor score
Top patents by PatentIndex Score
25 records- 0195US7939531B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted May 10, 2011·61 cites·32 claims
- 0295US7932254B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted Apr 26, 2011·60 cites·47 claims
- 0393US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 0492US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 0590US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 0689US11746100B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·2 cites·48 claims
- 0779US2023322704A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0878US2025109122A1Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0975US12202817B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 1075US11530191B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 1174US11286243B2Ferroportin inhibitors and methods of useGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·1 cites·24 claims
- 1274US2022402940A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1370US2022119407A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1467US11236109B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Feb 1, 2022·0 cites·8 claims
- 1567US10829470B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·11 claims
- 1666US9695166B2Pyrazolopyridine pyrazolopyrimidine and related compoundsGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Jul 4, 2017·1 cites·40 claims
- 1761US2015141465A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1856US10144746B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·0 cites·17 claims
- 1954US2018186807A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2053US9815853B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·16 claims
- 2152US2014155376A1Pyrrolopyrazine kinase inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2251US2023226074A1Methods of use for pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2343US11584734B2Tricyclic compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Feb 21, 2023·0 cites·45 claims
- 2442US2011288067A1Pyrrolopyrazine Kinase InhibitorsHENDRICKS ROBERT THAN·Filed 2011·Application pending·0 cites
- 2535US8329699B2Pyrrolopyrazine kinase inhibitorsHENDRICKS ROBERT THAN·Filed 2011·Granted Dec 11, 2012·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Calvin W. Yee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →